Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
Lijuan Zhu, Aihua Wang, Mei Gao, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
Э. А. Брага, М. В. Фридман, Alexey A. Moscovtsev, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8855-8855
Open Access | Times Cited: 196
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.
Pieterjan Ginckels, Paul Holvoet
PubMed (2022) Vol. 95, Iss. 1, pp. 129-152
Closed Access | Times Cited: 51
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Lokesh Kadian, Deepika Verma, Neelam Lohani, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3229-3254
Closed Access | Times Cited: 9
MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
Chenming Zhong, Zijun Xie, Linghui Zeng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
Majid Ghasemian, Masoumeh Rajabibazl, Unes Sahebi, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia
Xibao Yu, Cunte Chen, Yanyun Hu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 7, pp. 9055-9067
Open Access | Times Cited: 12
Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis
Shu Wang, Xianfeng Chen, Tiankui Qiao
Oncology Reports (2021) Vol. 45, Iss. 6
Open Access | Times Cited: 26
CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression
Mengna Zhang, Lingxian Zhang, Ajun Geng, et al.
Cell Reports (2022) Vol. 40, Iss. 11, pp. 111331-111331
Open Access | Times Cited: 19
Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review
Katarzyna Kwas, Maria Szubert, Jacek R. Wilczyński
Cells (2025) Vol. 14, Iss. 7, pp. 555-555
Open Access
Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks
Yang Liu, Pingan Lu, Xiaohui Yang, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12821-12838
Open Access | Times Cited: 22
Downregulation of long non‑coding RNA MR4435‑2HG suppresses breast cancer progression via the Wnt/β‑catenin signaling pathway
Deqin Chen, Pengting Tang, Yike Wang, et al.
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 21
MIR4435-2HG: A newly proposed lncRNA in human cancer
Menggang Zhang, Xiao Yu, Qiyao Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112971-112971
Open Access | Times Cited: 16
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
Lu Pei, Dong Yan, Qingqing He, et al.
Cellular Oncology (2023) Vol. 46, Iss. 5, pp. 1509-1527
Open Access | Times Cited: 9
Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer
Karolína Šeborová, Radka Václavíková, Lukáš Rob, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1839-1839
Open Access | Times Cited: 17
Identification of Autophagy- and Ferroptosis-Related lncRNAs Functioned through Immune-Related Pathways in Head and Neck Squamous Carcinoma
Qi Guo, Xuehan Zhang, Tao Shen, et al.
Life (2021) Vol. 11, Iss. 8, pp. 835-835
Open Access | Times Cited: 15
Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space
Petra M. Wise, Paolo Neviani, Stefan Riwaldt, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12841-12841
Open Access | Times Cited: 15
MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL
X. Torres, Jovanny Zabaleta, Nataly Cruz-Rodríguez, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis
Wei Feng, Dongya Zhang, Ruitao Zhang
Biological Procedures Online (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 14
LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Jing Ke, Quhui Wang, Wei Zhang, et al.
PubMed (2022) Vol. 14, Iss. 8, pp. 5441-5454
Closed Access | Times Cited: 9
A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in thyroid, pancreatic and ovarian cancer
Tushar Singh Barwal, Uttam Sharma, Manjit Kaur Rana, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 171, pp. 103598-103598
Closed Access | Times Cited: 8
Immune-Related Gene Expression Analysis Revealed Three lncRNAs as Prognostic Factors for Colon Cancer
Xiao‐Liang Xing, Ti Zhang, Zhi-Yong Yao, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 10
lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression
Tao Yang, Yan Li, Gang Wang, et al.
BioMed Research International (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 6
Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer
Gaomin Huang, Yawei Huang, Chiyu Zhang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma
Fengwei Li, Jianing Zhang, Jinchi Zhang, et al.
Genomics (2023) Vol. 115, Iss. 3, pp. 110621-110621
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top